Veeva Systems (VEEV) Stock Price, News & Analysis

Company Overview

Veeva Systems Inc. provides cloud-based software for the life sciences industry. It offers Veeva Commercial Cloud, a suite of software and analytics solutions, such as Veeva customer relationship management (CRM) that enable customer-facing employees at pharmaceutical and biotechnology companies; Veeva Vault PromoMats, an end-to-end content and digital asset management solution; Veeva Vault Medical that provides source of medical content across multiple channels and geographies; Veeva Crossix, an analytics platform for pharmaceutical brands; Veeva OpenData, a customer reference data solution; Veeva Link, a data application that allows link to generate real-time intelligence; and Veeva Compass includes de-identified and longitudinal patient data for the United States. The company also provides Veeva Development Cloud, a suite of applications for the clinical, regulatory, quality, and safety functions, including Veeva Vault Clinical, Veeva Vault RIM, Veeva Vault Safety, and Veeva Vault Quality; Veeva QualityOne, a quality and document management, and training solution; Veeva RegulatoryOne, a solution that helps companies to manage regulatory submission content; and Veeva Claims addresses the end-to-end product and marketing claims management process. In addition, it offers professional and support services, including implementation and deployment planning and project management; requirements analysis, solution design, and configuration; systems environment management and deployment services; services focused on advancing or transforming business and operating processes related to Veeva solutions; data migration and systems integrations technical consulting services; training on its solutions; and ongoing managed services, such as outsourced systems administration. The company was formerly known as Verticals onDemand, Inc. and changed its name to Veeva Systems Inc. in April 2009. Veeva Systems Inc. was incorporated in 2007 and is headquartered in Pleasanton, California.

Key Stats

• Today's Range: $232.15 to $234.53
• 50-Day Range: $209.34 to $242.48
• 52-Week Range: $170.25 to $258.93
• Volume: 858,455 shs
• Average Volume: 1.11 million shs
• Market Capitalization: $37.97 billion
• P/E Ratio: 57.63
• Dividend Yield: N/A
• Price Target: $254.92
• Consensus Rating: Moderate Buy

Veeva Systems Stock Analysis - MarketRank™

Veeva Systems scored higher than 80% of companies evaluated by MarketBeat, and ranked 202nd out of 919 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: 2.3 / 5
• Analyst Rating: Moderate Buy

Consensus Rating

Veeva Systems has received a consensus rating of Moderate Buy. The company's average rating score is 2.52, and is based on 15 buy ratings, 8 hold ratings, and 2 sell ratings.

Amount of Analyst Coverage

Veeva Systems has been the subject of 9 research reports in the past 90 days, demonstrating strong analyst interest in this stock.

Earnings and Valuation

• Score: 0.6 / 5
• Proj. Earnings Growth: 6.67%

Earnings Growth

Earnings for Veeva Systems are expected to grow by 6.67% in the coming year, from $4.35 to $4.64 per share.

Price to Earnings Ratio vs. the Market

The P/E ratio of Veeva Systems is 57.63, which means that it is trading at a more expensive P/E ratio than the market average P/E ratio of about 24.51.

Price to Earnings Ratio vs. Sector

The P/E ratio of Veeva Systems is 57.63, which means that it is trading at a more expensive P/E ratio than the Medical sector average P/E ratio of about 26.96.

Price to Earnings Growth Ratio

Veeva Systems has a PEG Ratio of 1.89. PEG Ratios above 1 indicate that a company could be overvalued.

Price to Book Value per Share Ratio

Veeva Systems has a P/B Ratio of 8.10. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

Short Interest

• Score: 5.0 / 5
• Short Interest Level: Healthy

Percentage of Shares Shorted

2.23% of the outstanding shares of Veeva Systems have been sold short.

Short Interest Ratio / Days to Cover

Veeva Systems has a short interest ratio ("days to cover") of 2.9, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Short interest in Veeva Systems has recently decreased by 6.68%, indicating that investor sentiment is improving significantly.

Dividend

• Score: 0.0 / 5
• Dividend Strength: N/A

Dividend Yield

Veeva Systems does not currently pay a dividend.

Dividend Growth

Veeva Systems does not have a long track record of dividend growth.

Sustainability and ESG

• Score: 2.9 / 5
• Environmental Score: -0.79

Percentage of Shares Shorted

2.23% of the outstanding shares of Veeva Systems have been sold short.

Short Interest Ratio / Days to Cover

Veeva Systems has a short interest ratio ("days to cover") of 2.9, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Short interest in Veeva Systems has recently decreased by 6.68%, indicating that investor sentiment is improving significantly.

News and Social Media

• Score: 3.5 / 5
• News Sentiment: 1.25

News Sentiment

Veeva Systems has a news sentiment score of 1.25. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.74 average news sentiment score of Medical companies.

News Coverage This Week

MarketBeat has tracked 34 news articles for Veeva Systems this week, compared to 17 articles on an average week.

Search Interest

Only 9 people have searched for VEEV on MarketBeat in the last 30 days. This is a decrease of 0% compared to the previous 30 days.

MarketBeat Follows

14 people have added Veeva Systems to their MarketBeat watchlist in the last 30 days. This is an increase of 27% compared to the previous 30 days.

Company Ownership

• Score: 3.3 / 5
• Insider Trading: Selling Shares

Insider Buying vs. Insider Selling

In the past three months, Veeva Systems insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $1,284,917.00 in company stock.

Percentage Held by Insiders

10.30% of the stock of Veeva Systems is held by insiders. A high percentage of insider ownership can be a sign of company health.

Percentage Held by Institutions

88.20% of the stock of Veeva Systems is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

VEEV Stock Analysis - Frequently Asked Questions

How have VEEV shares performed this year?

Veeva Systems' stock was trading at $210.25 at the start of the year. Since then, VEEV stock has increased by 11.0% and is now trading at $233.41.
View the best growth stocks for 2025 here.

How were Veeva Systems' earnings last quarter?

Veeva Systems Inc. (NYSE:VEEV) issued its quarterly earnings results on Wednesday, December, 6th. The technology company reported $1.34 EPS for the quarter, beating analysts' consensus estimates of $1.29 by $0.05. The firm's quarterly revenue was up 11.6% on a year-over-year basis.
Read the conference call transcript.

Does Veeva Systems have any subsidiaries?

Veeva Systems subsidiaries include these companies: Veeva RTSM, Veracity Logic, Learnaboutgmp, Physicians World, Veeva Crossix, Zinc Ahead Ltd, Selligy, and AdvantageMS.

Who are Veeva Systems' major shareholders?

Top institutional investors of Veeva Systems include Vanguard Group Inc. (9.07%), Alliancebernstein L.P. (3.38%), T. Rowe Price Investment Management Inc. (3.20%) and Price T Rowe Associates Inc. MD (2.45%). Insiders that own company stock include Matthew J Wallach, Thomas D Schwenger, Alan Mateo, Eleni Nitsa Zuppas, Paul Edward Chamberlain, Paul J Sekhri, Jonathan Faddis, Michele O'connor, Timothy S Cabral, Mary Lynne Hedley and Peter P Gassner.
View institutional ownership trends.

How do I buy shares of Veeva Systems?

Shares of VEEV stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

What other stocks do shareholders of Veeva Systems own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Veeva Systems investors own include Chevron (CVX), Bristol-Myers Squibb (BMY), Comcast (CMCSA), McKesson (MCK), Charles Schwab (SCHW), Edwards Lifesciences (EW) and Yum! Brands (YUM).

Company Calendar

• Last Earnings: 12/06/2023
• Today: 5/24/2025
• Next Earnings (Estimated): 5/28/2025
• Fiscal Year End: 1/31/2026

Industry, Sector and Symbol

• Stock Exchange: NYSE
• Sector: Medical
• Industry: Prepackaged software
• Sub-Industry: Computer Software
• Current Symbol: NYSE:VEEV
• CIK: 1393052
• Web: www.veeva.com
• Phone: (925) 452-6500
• Fax: 925-452-6504
• Employees: 5,480
• Year Founded: 2007

Price Target and Rating

• Average Stock Price Target: $254.92
• High Stock Price Target: $307.00
• Low Stock Price Target: $192.00
• Potential Upside/Downside: +9.2%
• Consensus Rating: Moderate Buy
• Rating Score (0-4): 2.52
• Research Coverage: 25 Analysts

Profitability

• EPS (Most Recent Fiscal Year): $4.33
• Trailing P/E Ratio: 57.63
• Forward P/E Ratio: 53.66
• P/E Growth: 1.89
• Net Income: $525.71 million
• Net Margins: 25.07%
• Pretax Margin: 32.26%
• Return on Equity: 13.56%
• Return on Assets: 11.02%

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: 6.36
• Quick Ratio: 6.36

Sales & Book Value

• Annual Sales: $2.75 billion
• Price / Sales: 13.83
• Cash Flow: $3.56 per share
• Price / Cash Flow: 65.58
• Book Value: $28.80 per share
• Price / Book: 8.10

Miscellaneous

• Outstanding Shares: 162,696,000
• Free Float: 145,303,000
• Market Cap: $37.97 billion
• Optionable: Optionable
• Beta: 0.96